ViaNautis Bio
VerifiedExploiting PolyNaut Technology to improve the therapeutic viability of molecules with poor pharmacokinetic and chemical properties and image live cells.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$106—158m (Dealroom.co estimates Nov 2023.)
Company register number 11617905
Cambridge England (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | £20.0m | Series A | |
| Total Funding | 000k | ||
Related Content
Recent News about ViaNautis Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.